CPRT - Copart, Inc.
Chart Events
Slow Stochastic
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 89.12 |
| Open | 89.45 |
| Bid | 84.72 x 1000 |
| Ask | 91.00 x 800 |
| Day's Range | 88.29 - 89.81 |
| 52 Week Range | 55.69 - 104.88 |
| Volume | 2,680,249 |
| Avg. Volume | 2,513,380 |
| Market Cap | 20.891B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 31.04 |
| EPS (TTM) | 2.88 |
| Earnings Date | May 20, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 88.75 |
Fair Value
Related Research
- Insider Monkey
Hedge Funds Aren’t Done Buying Copart, Inc. (CPRT)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2020. […]
- Motley Fool
Copart, Inc. (CPRT) Q3 2020 Earnings Call Transcript
At this time, I would like to turn the conference over to Jeff Liaw, President of Copart. Any forward-looking statements [Technical Issues] as of today and Copart [Technical Issues] obligation to update or revise any forward-looking statements.
- Zacks
Copart (CPRT) Q3 Earnings & Sales Miss Estimates, Down Y/Y
Copart's (CPRT) Q3 revenues and earnings per share come in lower than the prior-year quarter as well as miss the respective Zacks Consensus Estimate.
- Simply Wall St.
How Does Copart's (NASDAQ:CPRT) P/E Compare To Its Industry, After Its Big Share Price Gain?
Copart (NASDAQ:CPRT) shareholders are no doubt pleased to see that the share price has bounced 31% in the last month...
- Business Wire
Copart Reports Third Quarter Fiscal 2020 Financial Results
Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended April 30, 2020.
- Barrons.com
The Auto Market Is Improving Faster Than Expected. Check Out Advance Auto Parts’ Earnings.
Advance Auto Parts reported terrible earnings, but the results hint that things are looking up for the automotive universe. Same-store sales so far this quarter are about flat compared with last year’s.
- PR Newswire
Copart Opens New Location in Salt Lake City, Utah
Copart, Inc. (NASDAQ:CPRT), a global online vehicle auction company opened a new 45-acre location in Salt Lake City, Utah. This is Copart's second location in the state serving the growing needs of vehicle buyers and sellers. The other location is in Ogden.
- Simply Wall St.
At US$78.00, Is It Time To Put Copart, Inc. (NASDAQ:CPRT) On Your Watch List?
Copart, Inc. (NASDAQ:CPRT) received a lot of attention from a substantial price increase on the NASDAQGS over the last...
- Motley Fool
Why Shares of Carvana, AutoNation, and Copart Surged in April
What happened Shares of several companies related to the business of selling cars surged in April, as investors sought out companies that were well situated to weather the coronavirus pandemic and its likely economic aftermath.
- Investor's Business Daily
Ave Maria Growth Fund Excels With Do-Good Stocks
Ave Maria Growth Fund has made itself one of the best mutual funds by seeking stocks that do well as well as do good.
- GuruFocus.com
Insiders Roundup: National CineMedia, Cloudera
Largest insider trades of the week Continue reading...
- Simply Wall St.
Calculating The Intrinsic Value Of Copart, Inc. (NASDAQ:CPRT)
Does the April share price for Copart, Inc. (NASDAQ:CPRT) reflect what it's really worth? Today, we will estimate the...
- Investor's Business Daily
Copart Trying To Close In On Key Technical Measure
A Relative Strength Rating upgrade for Copart shows improving technical performance. Will it continue?
- GuruFocus.com
Video: 4 Large-Cap Stocks With Strong Buffett-Munger Characteristics
Editorial Assistant James Li seeks good investing opportunities using GuruFocus’ All-in-one Screener Continue reading...
- Simply Wall St.
How Does Copart's (NASDAQ:CPRT) P/E Compare To Its Industry, After The Share Price Drop?
To the annoyance of some shareholders, Copart (NASDAQ:CPRT) shares are down a considerable 36% in the last month. The...
- Insider Monkey
Hedge Funds Have Never Been This Bullish On Copart, Inc. (CPRT)
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- GuruFocus.com
Copart: A Great Business in a Great Niche
The company operates in a leading marketplace, has a high barrier to entry, is founder-led, has superior capital allocation and a natural hedge Continue reading...
- PR Newswire
Copart Announces New Location in Concord, North Carolina
Copart, Inc. (NASDAQ:CPRT), a global online vehicle auction company today announced the opening of a new location in Concord, North Carolina. This will be the sixth location in the state—a response to the increasing demands of automotive buyers and sellers.
- Thomson Reuters StreetEvents
Edited Transcript of CPRT earnings conference call or presentation 20-Feb-20 4:00pm GMT
Q2 2020 Copart Inc Earnings Call
- Investopedia
Copart Shares Could Be Ready to Bounce
Copart has been swept up in the global market rout, but looking back a few months, the stock was a massive outperformer.
- Simply Wall St.
Should You Be Impressed By Copart, Inc.'s (NASDAQ:CPRT) ROE?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- TipRanks
3 Monster Growth Stocks That Can Climb Higher as Market Plunges
Markets are plunging, taking a serious hit as the coronavirus spreads rapidly throughout the world. So far, the worst of the outbreak is in China, but large-scale viral cases are on the rise in Italy, Iran, and South Korea. Medical restrictions and quarantines are disrupting global trade and travel patterns, with shutdowns in Chinese factories impacting global supply chains in everything from electronics to the containerized shipping industry. The S&P 500 is down 12.8% from its peak on February 19, completely erasing earlier gains and putting the index at an 8.6% loss for the year to date.But as per usual in the stock markets, risky times also present opportunity for daring investors – and while the market as an aggregate is falling, any one stock’s individual performance may be very different. In short, a savvy investor can find stocks with serious growth potential, even in today’s market conditions.We’ve used TipRanks’ Stock Screener tool to pull up some stocks with serious growth prospects. Setting the filters to show us only mid- to large-cap stocks, with upwards of 20% upside potential, 6,100 stocks were reduced to a far more manageable 293. Let’s dive in and examine three of them in detail.Copart, Inc. (CPRT)We’ll start with Copart, the online automotive auction site. The Texas-based company boasts a global reach, with services in the US and Canada, UK and Ireland, Germany, Spain, and the UAE. The company offers services to sellers looking to unload used and salvaged vehicles, primarily in the dismantling, parts, and export markets. A limited number of vehicles are sold as used cars for the general public, but most of Copart’s customers are insurance companies.No matter what the stock market does, there will always be a market for used auto parts. That basic fact is reflected in Copart’s success. In the company’s most recent fiscal quarter, Q2 2020, reported last month, CPRT beat the forecasts and the year-over-year numbers, but the margins were narrow. Revenues came in at $575.1 million, up 18.6% year-over-year but only half a percent over estimates. EPS landed at 65 cents, right on the forecast.The earnings result for Q2 was the sixth in a row that the company met or surpassed the expectation, but shares slipped on an ominous sign: EPS growth was flat from Q1 to Q2. CPRT is down 19% since the quarterly report. It’s important to note here, however, that the quarterly earnings came out on February 19, the same day that markets started sliding on coronavirus fears.The combination of a general market slump and apparently slowing sales put a damper on the stock’s recent gains, but an important – and overlooked – point in today’s automotive market bodes well for CPRT. In the past 40 years, the rate at which cars are declared a ‘total loss’ after an accident has increased from 4% to 20%. At the same time, the number of cars on the road has increased dramatically. This puts a much larger population of sellable vehicles in Copart’s universe.At least one analyst sees CPRT’s current state as a good point of entry to the stock for investors. Craig Kennison, of Baird, writes, “Copart's earnings and revenues fell short of expectations and the modest slowdown was sufficient to break the momentum in the shares. We remain bullish on the shares as the fundamentals remain.”Along with his Buy rating, Kennison increased his price target on the stock by 4%, to $100. His new target suggests an upside potential of 18%. (To watch Kennison’s track record, click here)Overall, CPRT’s Strong Buy consensus rating is based on 3 Buys and 1 Hold, all set in the last two weeks. Shares are selling for $84.47, and the $106.33 average target price implies an upside growth potential of 26%. (See Copart stock analysis on TipRanks) Alnylam Pharmaceuticals, Inc. (ALNY)Next on our list is Alnylam, a biotech research company focused on RNAi commercialization for the treatment of genetic diseases. Biotechs are famously volatile, and companies are notorious for running steep losses until striking gold with a new drug approval. Alnylam falls squarely into that pattern, with the EPS loss at $2.47 in Q4 2019.Revenues, however, were up, coming in at $71.7 million. This beat the forecast by just under 1%. ALNY shares are up 46% in the past six months. The company has two drugs on the market, Onpattro and Givlaari, approved in 2018 and 2019, respectively, and reports growing sales revenues on both. Alnylam reported $55.8 million in Onpattro revenue for Q4 (up 21% from Q3), along with solid initial interest in Gilvaari. With another eight drugs in various stages of pipeline development, Alnylam has a firm foundation for future prospects.Chardan Capital analyst Keay Nakae is impressed by the growth potential here. He writes, “We believe that Alnylam is the clear leader in the RNAi space, as its scale, experience, patents, breadth of pipeline, and access to capital place it in an advantageous position relative to its competitors developing small RNA therapeutics. The Company's RNAi platform has been validated by the approval of two products (Onpattro and Givlarri), multiple positive phase III study results, including six last year…”Nakae puts a $190 price target behind his Buy rating, indicating confidence in a robust growth potential of 61% for the coming year. (To watch Nakae’s track record, click here)Alnylam has no fewer than 10 Buy ratings, outweighing the 1 Hold and 1 Sell as well as giving the stock a Strong Buy consensus rating. The average price target of $143.08 suggests a premium of 22% from the current share price of $117.55. (See Alnylam stock analysis on TipRanks) Anaplan, Inc. (PLAN)Anaplan is another company that had the bad fortune of reporting solid Q4 numbers just as the market hit a correction. The San Francisco-based company inhabits the cloud software ecosystem, offering customers event planning applications for business use. With the company’s platform, users can build and maintain strategic and operational business performance management systems.Like many high-tech companies, PLAN has been operating at a net loss, but the Q4 numbers showed the loss is narrowing. In non-GAAP reporting, PLAN posted a loss of 7 cents per share, comparing favorably to the 13-cent loss one year earlier. At the same time, total revenue rose by 42% to reach $98.2 million – that number included a 50% year-over-year increase in subscription revenue to $89.5 million.Writing from RBC Capital, 5-star analyst Alex Zukin says of this company, “We believe Anaplan is at the tip of the spear for digital transformation of financial and operational planning systems, a $21 billion-plus market with high barriers to entry and no pure-play competitors... With the company steadily building a broader strategic value proposition as a ‘System of Insights’ that can pull operational data from various systems of record we see the opportunity for the company to successfully scale to billions in revenue…”Zukin backs his Buy rating on the stock with a $75 price target, implying room for an impressive 67% upside growth this year. (To watch Zukin’s track record, click here)Zukin’s optimism is slightly higher than the consensus view of this stock. PLAN shares have a Strong Buy consensus rating, based on 4 Buys and 1 Hold set in recent weeks. The stock is selling for $44.88, and the average price target, $66.20, suggests a robust 48% upside potential. (See Anaplan price targets and analyst ratings on TipRanks)
- Investor's Business Daily
Stock Market Rally Pulls Back On Apple Warning, Coronavirus Fears; Domino's Delivers, Enphase, SolarEdge Shine; Morgan Stanley Buys E-Trade: Weekly Review
The stock market rally pulled back on coronavirus fears, including an Apple warning. Domino's Pizza, SolarEdge and Enphase Energy were big earnings winners.
- Investor's Business Daily
Dow Jones Falls 200 Points On Virus Concerns; Domino's Pizza Surges, While Twitter Nears A New Buy Point
The major stock indexes were squarely lower amid new coronavirus fears. Twitter stock has a new buy point.
- Zacks
Copart (CPRT) Q2 Earnings Meet Estimates, Sales Top, Up Y/Y
Copart (CPRT) Q2 earnings meet estimates on higher-than-anticipated service revenues and expanding network of facilities.
